DOCK9-AS1

Across TCGA pan-cancer cohorts, DOCK9-AS1 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of DOCK9-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where DOCK9-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types DOCK9-AS1 is over-expressed in tumor, although a few such as KICH and KIRP show the opposite, repressed pattern.

KICH, KIRP, and CHOL are the cancer types where DOCK9-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DOCK9-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	II,III,IV	−0.128	.004	7	view →
KIRP	Female	All	−0.149	<.001	5	view →
CHOL	All	All	−0.322	.021	2	view →
LIHC	Female	II,III,IV	−0.165	.016	2	view →
BRCA	All	III,IV	−0.142	.001	2	view →
LUSC	Female	All	−0.091	.009	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

DOCK9-AS1–KICH

Open the KICH breakdown →